Leslie Robison

992 total citations
8 papers, 701 citations indexed

About

Leslie Robison is a scholar working on Genetics, Neurology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Leslie Robison has authored 8 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 3 papers in Neurology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Leslie Robison's work include Acute Lymphoblastic Leukemia research (3 papers), Glioma Diagnosis and Treatment (3 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). Leslie Robison is often cited by papers focused on Acute Lymphoblastic Leukemia research (3 papers), Glioma Diagnosis and Treatment (3 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). Leslie Robison collaborates with scholars based in United States, France and Netherlands. Leslie Robison's co-authors include Charles A. Sklar, Ann Mertens, Daniel J. Green, Brian Greffe, Marilyn Stovall, Neyssa Marina, John Whitton, Anna T. Meadows, James G. Gurney and Joseph P. Neglia and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer and The Journal of Pediatrics.

In The Last Decade

Leslie Robison

8 papers receiving 679 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leslie Robison United States 7 357 292 152 138 123 8 701
Patricia H. Morris Jones United Kingdom 12 304 0.9× 221 0.8× 112 0.7× 115 0.8× 163 1.3× 22 805
G. Schellong Germany 11 277 0.8× 448 1.5× 117 0.8× 72 0.5× 96 0.8× 31 676
Hubert Caron Netherlands 12 218 0.6× 147 0.5× 81 0.5× 97 0.7× 139 1.1× 24 544
Hiroko Inada Japan 17 321 0.9× 236 0.8× 130 0.9× 171 1.2× 144 1.2× 49 817
E Whitehead United Kingdom 10 167 0.5× 370 1.3× 92 0.6× 47 0.3× 135 1.1× 15 704
Eva Hvizdala United States 16 186 0.5× 274 0.9× 243 1.6× 203 1.5× 148 1.2× 29 744
Melissa M. Hudson United States 11 178 0.5× 175 0.6× 116 0.8× 77 0.6× 94 0.8× 20 429
Biljana Novakovic United States 6 166 0.5× 123 0.4× 63 0.4× 84 0.6× 109 0.9× 6 496
A D Leiper United Kingdom 12 332 0.9× 375 1.3× 26 0.2× 77 0.6× 95 0.8× 15 626
Kala Y. Kamdar United States 14 404 1.1× 309 1.1× 57 0.4× 46 0.3× 150 1.2× 32 691

Countries citing papers authored by Leslie Robison

Since Specialization
Citations

This map shows the geographic impact of Leslie Robison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Robison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Robison more than expected).

Fields of papers citing papers by Leslie Robison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Robison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Robison. The network helps show where Leslie Robison may publish in the future.

Co-authorship network of co-authors of Leslie Robison

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Robison. A scholar is included among the top collaborators of Leslie Robison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Robison. Leslie Robison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Howell, Carrie R., Robyn E. Partin, Melissa M. Hudson, et al.. (2017). Peripheral Neuropathy, Function and Quality of Life in Adult Survivors of Childhood Acute Lymphoblastic Leukemia. Archives of Physical Medicine and Rehabilitation. 98(10). e91–e92. 1 indexed citations
2.
Su, Timothy, Stella M. Davies, Mary M. Davis, et al.. (2006). Expression of LINE-1 p40 protein in pediatric malignant germ cell tumors and its association with clinicopathological parameters: A report from the Children’s Oncology Group. Cancer Letters. 247(2). 204–212. 21 indexed citations
3.
Anderson, D. Mark, Kimberly Rennie, Richard Ziegler, et al.. (2001). Medical and neurocognitive late effects among survivors of childhood central nervous system tumors. Cancer. 92(10). 2709–2719. 83 indexed citations
4.
Sklar, Charles A., John Whitton, Ann Mertens, et al.. (2000). Abnormalities of the Thyroid in Survivors of Hodgkin’s Disease: Data from the Childhood Cancer Survivor Study1. The Journal of Clinical Endocrinology & Metabolism. 85(9). 3227–3232. 277 indexed citations
5.
Hamre, Merlın, Jonathan D. Buckley, Smita Bhatia, et al.. (1997). Langerhans cell histiocytosis: An exploratory epidemiologic study of 177 cases. Medical and Pediatric Oncology. 28(2). 92–97. 44 indexed citations
6.
Rapaport, Robert, Sharon E. Oberfield, Leslie Robison, et al.. (1995). Relationship of growth hormone deficiency and leukemia. The Journal of Pediatrics. 126(5). 759–761. 14 indexed citations
7.
Sklar, Charles A., Ann Mertens, Andrew W. Walter, et al.. (1993). Final height after treatment for childhood acute lymphoblastic leukemia: Comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation. The Journal of Pediatrics. 123(1). 59–64. 123 indexed citations
8.
Meadows, Anna T., Osvaldo Marrero, O. Oberlin, et al.. (1989). Second malignant neoplasms following childhood Hodgkin's disease: Treatment and splenectomy as risk factors. Medical and Pediatric Oncology. 17(5-6). 477–484. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026